References
- Yin F C, Spurgeon H A, Raizes O S, Greene H L, Weisfeldt M L, Shock N W. Age associated decrease in chronotropic response to isoproterenol. Circulation 1976; 54(II)167
- Vestal R E, Wood A JJ, Shand D G. Reduced beta-receptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181–6
- Ginsburg R, Bristow M R, Billingham M E, Stinson E B, Schroeder J S, Harrison D C. Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol. Am Heart J 1983; 106: 535–40
- Palmer G J, Ziegler M G, Lake C R. Response of norepinephrine and blood pressure to stress increases with age. J Gerontol 1978; 33: 482–7
- Barnes R F, Raskind M, Gumbrecht G, Halter J B. The effects of age on the plasma catecholamine response to mental stress in man. J Clin Endocrinol Metabol 1982; 54: 64–9
- Swedberg K, Hjalmarson Å, Holmberg S. Effects of work and acute beta-receptor blockade on myocardial noradrenaline release in congestive cardiomyopathy. Clin Cardiol 1979; 2: 424–30
- Francis G S, Goldsmith S R, Ziesche S M, Cohn J N. Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am J Cardiol 1982; 49: 1152–6
- Johansson G, Post B. Catecholamine output of males and females over a one-year period. Acta Physiol Scand 1974; 92: 557–65
- Frankenhaeuser M, Dunne E, Lundberg U. Sex differences in sympathetic-adrenal medullary reactions induced by different stressors. Psychopharmacology 1976; 47: 1–5
- Davidson L, Vandongen R, Rouse I L, Beilin L J, Tunney A. Sex-related differences in resting and stimulated plasma noradrenaline and adrenaline. Clin Science 1984; 67: 347–52
- Sanchez J, Pequignot J M, Peyrin L, Monod H. Sex differences in the sympatho-adrenal response to isometric exercise. Eur J Appl Physiol 1980; 45: 147–54
- Claustre J, Peyrin L, Fitoussi R, Mornex R. Sex differences in the adrenergic response to hypoglycemic stress in human. Psychopharmacology 1980; 67: 147–53
- Kenakin T P, Beek D. Is prenalterol (H133/80) really a selective beta1-adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships. J Pharm Exp Ther 1980; 213: 406–13
- Cleaveland C R, Rangno R E, Shand D G. A standardized isoproterenol sensitivity test. Arch Intern Med 1972; 130: 47–52
- Scott D HT, Arthur G R, Boyes R N, Scott D B. Cardiovascular effects of prenalterol (H133/22) in normal man. Br J Clin Pharmacol 1979; 7: 365–70
- Rönn O, Fellenius E, Graffner C, Johnsson G, Lundborg P, Svensson L. Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta-1-adrenoceptor agonist, prenalterol, in man. Eur J Clin Pharmacol 1980; 17: 81–6
- Rasmussen S, Hoilund-Carlsen P F, Hesse B, Hartling O J, Fabricius J, Dige-Petersen H, Giese J. Dose-response relationship in normal subjects of prenalterol a beta-adrenergic agonist with postive inotropic and resistance lowering effects. Eur J Clin Pharmacol 1984; 27: 539–43
- Klimmer F. Analyse Mentaler and Emotionater Beanspruchung des Arbeitenden Menschen. University of Darmstadt, DarmstadtWest Germany 1978; 219, Dissertation
- Christensen N J. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myx-oedema. Clin Sci Mol Med 1973; 45: 163–77
- Pedersen E B, Christensen N J. Catecholamines in plasma and urine in patients with essential hypertension determined by double-isotope derivative techniques. Acta Med Scand 1975; 198: 373–7
- Ziegler M G, Lake C R, Kopin I J. Plasma noradrenaline increases with age. Nature 1976; 261: 333–5
- Sever P S, Birch M, Osikowska B, Tunbridge R DG. Plasma-noradrenaline in essential hypertension. Lancet 1977; 1: 1078–81
- Brecht H M, Schoeppe W. Relation of plasma noradrenaline to blood pressure, age, sex and sodium balance in patients with stable essential hypertension and in normotensive subjects. Clin Sci Mol Med 1978; 55: 81–3
- Sever P S, Peart W S, Meade T W, Davies I B, Gordon D. Ethnic differences in blood pressure with observations on noradrenaline and rennin 1. A hospital hypertensive population. Clin Exp Hypertension 1979; 1: 745–60
- Thomas J A, Marks B H. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978; 41: 233–43
- Bristow M R, Ginsburg R, Minobe W, Cubicciotti R S, Scott-Sageman W, Lurie K, Billingham M E, Harrison D C, Stinson E B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982; 307: 205–11
- Stephenson R P. A modification of receptor theory. Br J Pharmacol 1956; 11: 379–93
- Furchgott R F. The use of beta-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of the receptor-agonist complexes. Adv Drug Res 1966; 3: 21–55
- Eisenhofer G, Lambie D G, Johnson R H. Beta-adrenoceptor responsiveness and plasma catecholamines as determinants of cardiovascular reactivity to mental stress. Clin Sci 1985; 69: 483–92